| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/1997 | EP0770082A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770080A1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
| 05/02/1997 | EP0770079A1 Heterobicyclic derivatives |
| 05/02/1997 | EP0770078A1 8-aryl-1,6-naphthyridin-5-ones |
| 05/02/1997 | EP0770077A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 05/02/1997 | EP0770076A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 05/02/1997 | EP0770074A1 Anti-helicobacter acyl derivatives of azolones |
| 05/02/1997 | EP0770073A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 05/02/1997 | EP0770072A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 05/02/1997 | EP0770071A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 05/02/1997 | EP0770070A1 Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate |
| 05/02/1997 | EP0770068A1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 05/02/1997 | EP0770066A1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
| 05/02/1997 | EP0770065A1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 05/02/1997 | EP0770064A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769968A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769966A1 Biotin compounds for targetting tumors and sites of infection |
| 05/02/1997 | EP0769965A1 Aqueous risperidone formulations |
| 05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0769953A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
| 05/02/1997 | EP0769951A1 Long-acting oxytetracycline composition |
| 05/02/1997 | EP0769950A1 Method and compound for the treatment of hair loss |
| 05/02/1997 | EP0769949A1 Hydromorphone therapy |
| 05/02/1997 | EP0769948A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769946A1 Methods of maintaining teeth and oral bone |
| 05/02/1997 | EP0769945A1 Methods for bone healing and fracture repair |
| 05/02/1997 | EP0769944A1 Methods for inhibiting bone prosthesis degeneration |
| 05/02/1997 | EP0769943A1 Methods of inhibiting demyelinating and dysmyelinating diseases |
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/02/1997 | EP0769939A1 Use of inhibitors of human s-cd23 |
| 05/02/1997 | EP0769937A1 Methods for inhibiting neuronal damage |
| 05/02/1997 | EP0769936A1 Self-emulsifying drug delivery system |
| 05/02/1997 | EP0769933A2 Alcoholic moisturizing after shave lotion |
| 05/02/1997 | EP0769917A1 Nervonic acid compositions |
| 05/02/1997 | EP0769904A1 Method for treating anxiety |
| 05/02/1997 | EP0769901A1 Two-and three-component fungicidal mixtures |
| 05/02/1997 | EP0707571B1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 05/02/1997 | EP0649410B1 Anilide derivatives |
| 05/02/1997 | EP0648202B1 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents |
| 05/02/1997 | EP0642525B1 Nucleosides being O-acylated with a mono-unsaturated omega-9 C18 or C20 fatty acid |
| 05/02/1997 | EP0628039B1 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 05/02/1997 | EP0623024B1 Pharmaceutical bacteriocin compositions and their use for treating gastrointestinal disorders |
| 05/02/1997 | EP0590024B1 Topical composition enhancing healing of herpes lesions |
| 05/02/1997 | EP0544760B1 Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 05/01/1997 | WO1997015686A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | WO1997015685A1 NUCLEIC ACID MOLECULES CAPABLE OF DISTINGUISHING THE ISOFORMS PrPc AND PrPSc OF PRION PROTEINS AND PROCESSES FOR THEIR PRODUCTION |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015662A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015595A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015579A1 Production of a crystalline salt of amoxicillin |
| 05/01/1997 | WO1997015578A1 Papyracillic acid, method for preparation and its use as synthon for bioactive substances |
| 05/01/1997 | WO1997015577A1 Reverse-turn mimetics and methods relating thereto |
| 05/01/1997 | WO1997015574A1 Polymorphic forms of a growth hormone secretagogue |
| 05/01/1997 | WO1997015572A1 Lubeluzole n-oxide |
| 05/01/1997 | WO1997015571A1 Method for treating cancer using taxoid onium salt prodrugs |
| 05/01/1997 | WO1997015570A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 05/01/1997 | WO1997015569A1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide |
| 05/01/1997 | WO1997015568A1 Fibrinogen receptor antagonist |
| 05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 05/01/1997 | WO1997015564A1 4-oxa and 4-thia steroids |
| 05/01/1997 | WO1997015562A1 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor |
| 05/01/1997 | WO1997015561A1 Chiral methyl phenyl oxazolidinones |
| 05/01/1997 | WO1997015558A1 17-alkyl-7-substituted-4-aza steroid derivatives |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015555A2 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
| 05/01/1997 | WO1997015550A1 Fluoro-substituted benzoylpropionic acid derivatives |
| 05/01/1997 | WO1997015548A1 New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015329A1 Stabilised pharmaceutical compositions containing dobutamine |
| 05/01/1997 | WO1997015328A1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 05/01/1997 | WO1997015327A1 Methods of treating established colitis using antibodies against il-12 |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015324A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents |
| 05/01/1997 | WO1997015321A1 Pharmaceutical composition containing an activin or inhibin stimulator |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015315A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 05/01/1997 | WO1997015313A1 Therapeutic use of hemoglobin in promoting wound healing |
| 05/01/1997 | WO1997015312A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015311A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015309A1 Method of inhibiting sleep apnea |
| 05/01/1997 | WO1997015308A1 Compositions and methods for treating bone deficit conditions |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | WO1997015306A1 Infusions of neuroprotectants and perfluorochemicals |
| 05/01/1997 | WO1997015304A1 Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 05/01/1997 | WO1997015303A1 Treating disorders mediated by vascular smooth muscle cell proliferation |